Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors.
Saved in:
| Title: | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors. |
|---|---|
| Authors: | Mispelbaum R; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Hattenhauer ST; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Brossart P; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Heine A; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Sep 08; Vol. 13, pp. 976011. Date of Electronic Publication: 2022 Sep 08 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2022.976011 |
